Unique clinical conditions associated with different acinar regions of fibrosis in long-term surviving pediatric liver grafts

Pediatr Transplant. 2017 Nov;21(7). doi: 10.1111/petr.12988. Epub 2017 Jun 18.

Abstract

In the majority of long-term survivors after PLTx, graft fibrosis has been identified. Recently, subtypes of graft fibrosis have been described based on their predominant acinar localization. We aimed to evaluate whether the development of portal, perisinusoidal, and centrilobular distribution of graft fibrosis is related to patient or transplantation-related parameters. We reviewed the histological features in protocol liver biopsies taken at 1 and 5 years after PLTx of 47 children on a tacrolimus-based immunosuppressive regimen. Fibrosis was assessed according to the LAFSc. The prevalence of portal fibrosis increased from 31% to 62%, sinusoidal from 68% to 79%, and centrilobular from 76% to 85%. The presence of portal fibrosis was associated with total bilirubin and γGT levels (each P<.02) and tended to be associated with biliary complications (P=.06). Sinusoidal fibrosis was associated with prior rejection episodes (P<.02) and centrilobular fibrosis with the presence of HLA mismatches (P=.02). In conclusion, using the LAFSc, we found a high incidence of progressive fibrosis in the 1-year and 5-year protocol biopsies after PLTx. Progression of fibrosis was observed in all acinar compartments, and each of the three locations is associated with different clinical conditions.

Keywords: LAFSc; graft fibrosis; liver; pediatric; tacrolimus; transplantation.

MeSH terms

  • Adolescent
  • Biopsy
  • Child
  • Child, Preschool
  • Disease Progression
  • Female
  • Follow-Up Studies
  • Graft Rejection / diagnosis
  • Graft Rejection / pathology
  • Graft Rejection / prevention & control
  • Humans
  • Immunosuppressive Agents / therapeutic use
  • Incidence
  • Infant
  • Infant, Newborn
  • Liver / pathology
  • Liver Cirrhosis / diagnosis
  • Liver Cirrhosis / epidemiology
  • Liver Cirrhosis / etiology*
  • Liver Cirrhosis / pathology
  • Liver Transplantation*
  • Male
  • Postoperative Complications / diagnosis
  • Postoperative Complications / epidemiology
  • Postoperative Complications / etiology*
  • Postoperative Complications / pathology
  • Prevalence
  • Retrospective Studies
  • Risk Factors
  • Tacrolimus / therapeutic use

Substances

  • Immunosuppressive Agents
  • Tacrolimus